title: Takeda's Oncology Discovery Strategy.
abstract: Takeda's Oncology Discovery Strategy is tightly integrated and focused on first and fast-best-in-class products and product combinations. Core areas of expertise include hormones, protein homeostasis, biotherapeutics and signal transduction. Strategic imperatives for research success are understanding of unmet needs, focus on biological expertise in foundational areas of leadership and flexibility to adapt to new information.
authors.affiliation: Millennium Pharmaceuticals, Inc., Cambridge, MA, USA.
authors.forename: Brian
authors.initials: B
authors.lastname: DeSchuytner
authors.forename: Kyle
authors.initials: K
authors.lastname: Kuvalanka
authors.forename: Barbara
authors.initials: B
authors.lastname: Hibner
authors.forename: Joseph
authors.initials: J
authors.lastname: Bolen
mesh_terms: D000970:Antineoplastic Agents; D001688:Biological Products / Q000627:therapeutic use; D002140:California; D004345:Drug Industry; D006706:Homeostasis / Q000502:physiology; D006728:Hormones / Q000627:therapeutic use; D007564:Japan; D011506:Proteins / Q000502:physiology; D012106:Research
chemical_list: D000970:Antineoplastic Agents; D001688:Biological Products; D006728:Hormones; D011506:Proteins